Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Cleveland Clinic, Fox Chase Cancer Center, Ministry of Health, Dnipropetrovsk State Medical Academy, Federal State Budgetary Institution Russian Scientific Center of Roentgenoradiology, The Christie NHS Foundation Trust, Central Clinical Hospital and Polyclinic, Université Laval, P.A. Hertzen Moscow Oncology Research Institute, Centre Hospitalier de l’Université de Montréal, Palacký University Olomouc, Sumy State University, Ivano-Frankivsk National Medical University, Hospital de Clínicas de Porto Alegre, Université Côte d'Azur, Centre Antoine Lacassagne, Wojskowy Instytut Medycyny Lotniczej, Rocky Mountain Cancer Centers, University College Dublin, Tallaght University Hospital, University of Tübingen, Lyon College, Taipei Veterans General Hospital, Osaka City University Hospital, Merck & Co., Inc., Rahway, NJ, USA (United States), Georgetown Lombardi Comprehensive Cancer Center, Queen Mary University of London, University College London, The Royal Free Hospital, Barts Health NHS Trust